Grantham, Mayo, Van Otterloo & Co (GMO)
DNY

Grantham, Mayo, Van Otterloo & Co (GMO)’s DONNELLEY R R & SONS CO DNY Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio DNY Stock Details DNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-600,000
Closed -$9.43M – 574
2016
Q3 		$9.43M Buy
+600,000
New +$9.43M 0.04% 209

Other funds holding DNY

SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
MA
Marshwinds Advisory St Simons Island, Georgia $187M AUM 1.79% 1-Year Est. Return
DVM
Dreman Value Management West Palm Beach, Florida $221M AUM 11.98% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s DNY Position: Q4 2016 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of DONNELLEY R R & SONS CO (DNY) in Q4 2016, closing a stake of 435,100 shares — an estimated $6.84M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DNY in Q2 2013 and held it in 7 quarters. The position peaked at $6.84M in Q3 2016. 6 funds tracked by Wall St. Rank hold DNY as of Q4 2016.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining DONNELLEY R R & SONS CO position as of Q4 2016 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 435,100 DONNELLEY R R & SONS CO shares in Q4 2016, an estimated $6.84M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DONNELLEY R R & SONS CO in Q2 2013 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s DONNELLEY R R & SONS CO position peaked at $6.84M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held DONNELLEY R R & SONS CO as of Q4 2016.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2016, filed 13 Feb 2017.